Open questions and misconceptions in the diagnosis and management of anemia in patients with gastrointestinal bleeding

Bager, 2013, Lack of follow-up of anaemia after discharge from an upper gastrointestinal bleeding centre, Dan Med J, 60, A4583 Beale, 2005, The prevalence of iron deficiency among patients presenting with colorectal cancer, Colorectal Dis, 7, 398, 10.1111/j.1463-1318.2005.00789.x Carrott, 2013, Iron-deficiency anemia is a common presenting issue with giant paraesophageal hernia and resolves following repair, J. Gastrointest. Surg., 17, 858, 10.1007/s11605-013-2184-7 Hesham, 2004, Intestinal parasitic infections and micronutrient deficiency: a review, Med J Malays, 59, 284 Kubo, 1985, Studies on complications of diverticular disease of the colon, Jpn. J. Med., 24, 39, 10.2169/internalmedicine1962.24.39 Wierdsma, 2013, Vitamin and mineral deficiencies are highly prevalent in newly diagnosed celiac disease patients, Nutrients, 5, 3975, 10.3390/nu5103975 Kim, 2014, Diagnosis of gastrointestinal bleeding: a practical guide for clinicians, World J Gastrointest Pathophysiol, 5, 467, 10.4291/wjgp.v5.i4.467 Laine, 2012, Trends for incidence of hospitalization and death due to GI complications in the United States from 2001 to 2009, Am. J. Gastroenterol., 107, 1190, 10.1038/ajg.2012.168 Adam, 2008, Estimates of costs of hospital stay for variceal and nonvariceal upper gastrointestinal bleeding in the United States, Value Health, 11, 1, 10.1111/j.1524-4733.2007.00208.x Kim, 2014, Causes of bleeding and outcomes in patients hospitalized with upper gastrointestinal bleeding, J. Clin. Gastroenterol., 48, 113, 10.1097/MCG.0b013e318297fb40 Lanas, 2011, The changing face of hospitalisation due to gastrointestinal bleeding and perforation, Aliment. Pharmacol. Ther., 33, 585, 10.1111/j.1365-2036.2010.04563.x Goddard, 2011, Guidelines for the management of iron deficiency anaemia, Gut, 60, 1309, 10.1136/gut.2010.228874 Marignani, 2005, Occult and obscure bleeding, iron deficiency anemia and other gastrointestinal stories (Review), Int. J. Mol. Med., 15, 129 Zhu, 2010, Evaluation and treatment of iron deficiency anemia: a gastroenterological perspective, Dig. Dis. Sci., 55, 548, 10.1007/s10620-009-1108-6 Bosch, 2016, Factors associated with hospitalization among emergency department patients referred for quick investigation of iron-deficiency anemia, J. Emerg. Med., 50, 394, 10.1016/j.jemermed.2015.08.010 Bayraktar, 2010, Treatment of iron deficiency anemia associated with gastrointestinal tract diseases, World J. Gastroenterol., 16, 2720, 10.3748/wjg.v16.i22.2720 Murphy, 1986, Relation of haemoglobin levels in first and second trimesters to outcome of pregnancy, Lancet, 1, 992, 10.1016/S0140-6736(86)91269-9 Vashistha, 2016, Red cell distribution width and mortality in hemodialysis patients, Am. J. Kidney Dis., 68, 110, 10.1053/j.ajkd.2015.11.020 Viteri, 1994, The consequences of iron deficiency and anaemia in pregnancy on maternal health, the foetus and the infant, SCN News, 14 Stein, 2016, Anemia and iron deficiency in gastrointestinal and liver conditions, World J. Gastroenterol., 22, 7908, 10.3748/wjg.v22.i35.7908 Gasche, 2007, Guidelines on the diagnosis and management of iron deficiency and anemia in inflammatory bowel diseases, Inflamm. Bowel Dis., 13, 1545, 10.1002/ibd.20285 Stein, 2010, Diagnosis and management of iron deficiency anemia in patients with IBD, Nat Rev Gastroenterol Hepatol, 7, 599, 10.1038/nrgastro.2010.151 Gisbert, 2008, Common misconceptions in the diagnosis and management of anemia in inflammatory bowel disease, Am. J. Gastroenterol., 103, 1299, 10.1111/j.1572-0241.2008.01846.x Busti, 2014, Iron deficiency in the elderly population, revisited in the hepcidin era, Front Pharmacol, 5, 83, 10.3389/fphar.2014.00083 Careaga, 2015, Inflammation and iron status in bariatric surgery candidates, Surg Obes Relat Dis, 11, 906, 10.1016/j.soard.2014.09.028 Gesquiere, 2014, Medication cost is significantly reduced after Roux-en-Y gastric bypass in obese patients, Obes. Surg., 24, 1896, 10.1007/s11695-014-1325-8 Malone, 2013, Comparative review of the safety and efficacy of ferric carboxymaltose versus standard medical care for the treatment of iron deficiency anemia in bariatric and gastric surgery patients, Obes. Surg., 23, 1413, 10.1007/s11695-013-0939-6 Malone, 2013, Management of iron deficiency and anemia after Roux-en-Y gastric bypass surgery: an observational study, Surg Obes Relat Dis, 9, 969, 10.1016/j.soard.2013.01.019 Franceschi, 2014, Clinical effects of Helicobacter pylori outside the stomach, Nat Rev Gastroenterol Hepatol, 11, 234, 10.1038/nrgastro.2013.243 Kassebaum, 2014, Global, regional, and national levels and causes of maternal mortality during 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013, Lancet, 384, 980, 10.1016/S0140-6736(14)60696-6 Mearin, 2013, Prevalence and characteristics of anemia and iron deficiency in patients hospitalized for gastrointestinal diseases in Spain, Gastroenterol. Hepatol., 36, 499, 10.1016/j.gastrohep.2013.05.006 Gasche, 2000, Anemia in IBD: the overlooked villain, Inflamm. Bowel Dis., 6, 142, 10.1097/00054725-200005000-00013 Gasche, 2004, Iron, anaemia, and inflammatory bowel diseases, Gut, 53, 1190, 10.1136/gut.2003.035758 Bager, 2014, Patient-reported outcomes after acute nonvariceal upper gastrointestinal hemorrhage, Scand. J. Gastroenterol., 49, 909, 10.3109/00365521.2014.910544 Sousa, 2003, Symptom status and health-related quality of life: clinical relevance, J. Adv. Nurs., 42, 571, 10.1046/j.1365-2648.2003.02660.x Goodnough, 2004, Anemia and its clinical consequences in patients with chronic diseases, Am. J. Med., 116, 1S, 10.1016/j.amjmed.2003.12.007 Haas, 2001, Iron deficiency and reduced work capacity: a critical review of the research to determine a causal relationship, J. Nutr., 131, 676S, 10.1093/jn/131.2.676S Wells, 2006, Effects of changes in hemoglobin level on quality of life and cognitive function in inflammatory bowel disease patients, Inflamm. Bowel Dis., 12, 123, 10.1097/01.MIB.0000196646.64615.db Wilson, 2004, Prevalence and outcomes of anemia in inflammatory bowel disease: a systematic review of the literature, Am. J. Med., 116, 44S, 10.1016/j.amjmed.2003.12.011 Evstatiev, 2011, FERGIcor, a randomized controlled trial on ferric carboxymaltose for iron deficiency anemia in inflammatory bowel disease, Gastroenterology, 141, 846, 10.1053/j.gastro.2011.06.005 Murray-Kolb, 2007, Iron treatment normalizes cognitive functioning in young women, Am. J. Clin. Nutr., 85, 778, 10.1093/ajcn/85.3.778 Bruner, 1996, Randomised study of cognitive effects of iron supplementation in non-anaemic iron-deficient adolescent girls, Lancet, 348, 992, 10.1016/S0140-6736(96)02341-0 Favrat, 2014, Evaluation of a single dose of ferric carboxymaltose in fatigued, iron-deficient women – PREFER a randomized, placebo-controlled study, PLoS ONE, 9, e94217, 10.1371/journal.pone.0094217 Planella de Rubinat, 2015, Incidence and predictive factors of iron deficiency anemia after acute non-variceal upper gastrointestinal bleeding without portal hypertension [Spanish], Gastroenterol. Hepatol., 38, 525, 10.1016/j.gastrohep.2015.02.012 Stein, 2013, Anaemia management in patients with inflammatory bowel disease: routine practice across nine European countries, Eur. J. Gastroenterol. Hepatol., 25, 1456, 10.1097/MEG.0b013e328365ca7f Wish, 2006, Assessing iron status: beyond serum ferritin and transferrin saturation, Clin J Am Soc Nephrol, 1, S4, 10.2215/CJN.01490506 Peyrin-Biroulet, 2015, Guidelines on the diagnosis and treatment of iron deficiency across indications: a systematic review, Am. J. Clin. Nutr., 102, 1585, 10.3945/ajcn.114.103366 Dignass, 2015, European consensus on the diagnosis and management of iron deficiency and anaemia in inflammatory bowel diseases, J Crohns Colitis, 9, 211, 10.1093/ecco-jcc/jju009 Van Assche, 2013, Second European evidence-based consensus on the diagnosis and management of ulcerative colitis. Part 3: Special situations, J Crohns Colitis, 7, 1, 10.1016/j.crohns.2012.09.005 Weiss, 2005, Anemia of chronic disease, N. Engl. J. Med., 252, 1011, 10.1056/NEJMra041809 Dubois, 2006, Identification, diagnosis, and management of anemia in adult ambulatory patients treated by primary care physicians: evidence-based and consensus recommendations, Curr. Med. Res. Opin., 22, 385, 10.1185/030079906X89720 Anker, 2009, Ferric carboxymaltose in patients with heart failure and iron deficiency, N. Engl. J. Med., 361, 2436, 10.1056/NEJMoa0908355 Ponikowski, 2015, Beneficial effects of long-term intravenous iron therapy with ferric carboxymaltose in patients with symptomatic heart failure and iron deficiency, Eur. Heart J., 36, 657, 10.1093/eurheartj/ehu385 González Alayón, 2016, Prevalencia de deficit de hierro sin anemia en la enfermedad inflamatoria intestinal y su impacto en la calidad de vida [Spanish], Gastroenterol. Hepatol., 39, 40 Taylor, 2014, The management of acute upper gastrointestinal bleeding: a comparison of current clinical guidelines and best practice, EMJ Gastroenterol, 3, 73, 10.33590/emjgastroenterol/10314028 Jericó, 2016, Tratamiento de anemia secundaria a hemorragia digestiva con hierro carboximaltosa intravenoso en un hospital de día médico [Spanish], Gastroenterol. Hepatol., 39, 118 López-Suárez, 2016, Ferroterapia intravenosa en pacientes con angiodisplasia gastrointestinal [Spanish], Gastroenterol. Hepatol., 39, 106 Hernandez-Diaz, 2000, Association between nonsteroidal anti-inflammatory drugs and upper gastrointestinal tract bleeding/perforation: An overview of epidemiologic studies published in the 1990s, Arch. Intern. Med., 160, 2093, 10.1001/archinte.160.14.2093 Laine, 2006, Systematic review: the lower gastrointestinal adverse effects of non-steroidal anti-inflammatory drugs, Aliment. Pharmacol. Ther., 24, 751, 10.1111/j.1365-2036.2006.03043.x Geisser, 2011, The pharmacokinetics and pharmacodynamics of iron preparations, Pharmaceutics, 3, 12, 10.3390/pharmaceutics3010012 Muñoz, 2012, Ferric carboxymaltose for the treatment of iron-deficiency anemia [corrected], Expert Opin. Pharmacother., 13, 907, 10.1517/14656566.2012.669373 Young, 2008, Relation of low hemoglobin and anemia to morbidity and mortality in patients hospitalized with heart failure (insight from the OPTIMIZE-HF registry), Am. J. Cardiol., 101, 223, 10.1016/j.amjcard.2007.07.067 Crawford, 2002, Relationship between changes in hemoglobin level and quality of life during chemotherapy in anemic cancer patients receiving epoetin alfa therapy, Cancer, 95, 888, 10.1002/cncr.10763 Kulnigg, 2009, Rapid recurrence of IBD-associated anemia and iron deficiency after intravenous iron sucrose and erythropoietin treatment, Am. J. Gastroenterol., 104, 1460, 10.1038/ajg.2009.114 Chertow, 2006, Update on adverse drug events associated with parenteral iron, Nephrol. Dial. Transplant., 21, 378, 10.1093/ndt/gfi253 European Medicines Agency. Assessment report for: iron containing intravenous (IV) medicinal products. Available from: http://www.ema.europa.eu/docs/en_GB/document_library/Referrals_document/IV_iron_31/WC500150771.pdf [accessed 20.05.17]. Steinmetz, 2013, Clinical experience with ferric carboxymaltose in the treatment of cancer and chemotherapy-associated anaemia, Ann. Oncol., 24, 475, 10.1093/annonc/mds338 Toledano, 2016, Clinical use of ferric carboxymaltose in patients with solid tumours or haematological malignancies in France, Support. Care Cancer, 24, 67, 10.1007/s00520-015-2728-3 Garrow, 2010, Risk factors for gastrointestinal ulcer disease in the US population, Dig. Dis. Sci., 55, 66, 10.1007/s10620-008-0708-x Lee, 2015, Different risk of common gastrointestinal disease between groups undergoing hemodialysis or peritoneal dialysis or with non-end stage renal disease: a nationwide population-based cohort study, Medicine (Baltimore)., 94, e1482, 10.1097/MD.0000000000001482 Liang, 2016, Upper gastrointestinal bleeding as a risk factor for dialysis and all-cause mortality: a cohort study of chronic kidney disease patients in Taiwan, BMJ Open, 6, e010439, 10.1136/bmjopen-2015-010439 2012, KDIGO clinical practice guideline for anemia in chronic kidney disease, Kidney Inter Suppl, 2, 279 Evstatiev, 2012, Iron sensing and signalling, Gut, 61, 933, 10.1136/gut.2010.214312 Kulnigg, 2008, A novel intravenous iron formulation for treatment of anemia in inflammatory bowel disease: the ferric carboxymaltose (FERINJECT) randomized controlled trial, Am. J. Gastroenterol., 103, 1182, 10.1111/j.1572-0241.2007.01744.x Reinisch, 2013, A randomized, open-label, non-inferiority study of intravenous iron isomaltoside 1000 (Monofer) compared with oral iron for treatment of anemia in IBD (PROCEED), Am. J. Gastroenterol., 108, 1877, 10.1038/ajg.2013.335 Ganzoni, 1970, Intravenous iron-dextran: therapeutic and experimental possibilities, Schweiz. Med. Wochenschr., 100, 301 Vifor Pharma. Summary of Product Characteristics, Ferinject®. Available from: http://www.mhra.gov.uk/home/groups/spcpil/documents/spcpil/con1470978881197.pdf [accessed 20.05.17]. Evstatiev, 2013, Ferric carboxymaltose prevents recurrence of anemia in patients with inflammatory bowel disease, Clin Gastroenterol Hepatol, 11, 269, 10.1016/j.cgh.2012.10.013 Bager, 2014, Randomised clinical trial: oral vs. intravenous iron after upper gastrointestinal haemorrhage – a placebo-controlled study, Aliment. Pharmacol. Ther., 39, 176, 10.1111/apt.12556 Lindgren, 2009, Intravenous iron sucrose is superior to oral iron sulphate for correcting anaemia and restoring iron stores in IBD patients: a randomized, controlled, evaluator-blind, multicentre study, Scand. J. Gastroenterol., 44, 838, 10.1080/00365520902839667 Koskenkorva-Frank, 2013, The complex interplay of iron metabolism, reactive oxygen species, and reactive nitrogen species: insights into the potential of various iron therapies to induce oxidative and nitrosative stress, Free Radic. Biol. Med., 65, 1174, 10.1016/j.freeradbiomed.2013.09.001 Beshara, 1999, Pharmacokinetics and red cell utilization of iron(III) hydroxide-sucrose complex in anaemic patients: a study using positron emission tomography, Br. J. Haematol., 104, 296, 10.1046/j.1365-2141.1999.01179.x Beshara, 2003, Pharmacokinetics and red cell utilization of 52Fe/59Fe-labelled iron polymaltose in anaemic patients using positron emission tomography, Br. J. Haematol., 120, 853, 10.1046/j.1365-2141.2003.03590.x López-Suárez, 2016, Tratamiento con carboximaltosa de hierro en pacientes derivados por la unidad de digestivo [Spanish], Gastroenterol. Hepatol., 39, 105 Ferrer-Barceló, 2016, Tratamiento de la anemia ferropénica posthemorragia digestiva aguda: ferroterapia oral frente a intravenosa [Spanish], Gastroenterol. Hepatol., 39, 133 Torres Vicente, 2016, Efficacy and safety of ferric carboxymaltose treatment in patients hospitalized for acute gastrointestinal bleeding not associated with portal hypertension [Spanish], Gastroenterol. Hepatol., 40, 159 Calleja, 2016, Ferric carboxymaltose reduces transfusions and hospital stay in patients with colon cancer and anemia, Int. J. Colorectal Dis., 31, 543, 10.1007/s00384-015-2461-x Edwards, 2009, Randomized clinical trial of preoperative intravenous iron sucrose to reduce blood transfusion in anaemic patients after colorectal cancer surgery, Br. J. Surg., 96, 1122, 10.1002/bjs.6688 Muñoz, 2015, ‘Fit to fly’: overcoming barriers to preoperative haemoglobin optimization in surgical patients, Br. J. Anaesth., 115, 15, 10.1093/bja/aev165 Canadian Agency for Drugs and Technologies in Health. Ferumoxytol versus other intravenous iron therapies for anemia: a review of the clinical and cost-effectiveness and guidelines – an update. PM: 25520994 [accessed 1.02.16]. European Medicines Agency. Rienso. Withdrawal of the marketing authorisation in the European Union. Available from: www.ema.europa.eu/docs/en_GB/document_library/Public_statement/2015/07/WC500189474.pdf [accessed 27.04.17] Auerbach, 2007, Clinical update: intravenous iron for anaemia, Lancet, 369, 1502, 10.1016/S0140-6736(07)60689-8 Bailie, 2012, Adverse events associated with intravenous iron preparations: a comparison of reported rates, Clin Adv Hematol Oncol, 10, 600 Avni, 2015, The safety of intravenous iron preparations: systematic review and meta-analysis, Mayo Clin. Proc., 90, 12, 10.1016/j.mayocp.2014.10.007 Jairath, 2015, Restrictive versus liberal blood transfusion for acute upper gastrointestinal bleeding (TRIGGER): a pragmatic, open-label, cluster randomised feasibility trial, Lancet, 386, 137, 10.1016/S0140-6736(14)61999-1 Villanueva, 2015, Gastrointestinal bleeding: blood transfusion for acute upper gastrointestinal bleeding, Nat Rev Gastroenterol Hepatol, 12, 432, 10.1038/nrgastro.2015.116 Villanueva, 2013, Transfusion strategies for acute upper gastrointestinal bleeding, N. Engl. J. Med., 368, 11, 10.1056/NEJMoa1211801 Salvadori, 2016, Ferric carboxymaltose reduces the number of red blood cell units transfused and allows transfusion independence to be obtained in patients with iron deficiency anemia secondary to gastrointestinal chronic blood loss, Transfusion (Paris), 56, 2720, 10.1111/trf.13794 American Association of Blood Banks. Five things physicians and patients should question. Available from: http://www.choosingwisely.org/wp-content/uploads/2015/02/AABB-Choosing-Wisely-List.pdf [accessed 3.08.17]. Laine, 2016, CLINICAL PRACTICE. Upper gastrointestinal bleeding due to a peptic ulcer, N. Engl. J. Med., 374, 2367, 10.1056/NEJMcp1514257 Zlotkin, 2001, Randomized, controlled trial of single versus 3-times-daily ferrous sulfate drops for treatment of anemia, Pediatrics, 108, 613, 10.1542/peds.108.3.613 Rockey, 2006, Treatment of iron deficiency, Gastroenterology, 130, 1367, 10.1053/j.gastro.2005.12.051 Rimon, 2005, Are we giving too much iron? Low-dose iron therapy is effective in octogenarians, Am. J. Med., 118, 1142, 10.1016/j.amjmed.2005.01.065 Makrides, 2003, Efficacy and tolerability of low-dose iron supplements during pregnancy: a randomized controlled trial, Am. J. Clin. Nutr., 78, 145, 10.1093/ajcn/78.1.145 Alleyne, 2008, Individualized treatment for iron-deficiency anemia in adults, Am. J. Med., 121, 943, 10.1016/j.amjmed.2008.07.012 Allen, 2002, Iron supplements: scientific issues concerning efficacy and implications for research and programs, J. Nutr., 132, 813s, 10.1093/jn/132.4.813S Berg, 1993, Medication compliance: a healthcare problem, Ann. Pharmacother., 27, S1 Partridge, 2003, Nonadherence to adjuvant tamoxifen therapy in women with primary breast cancer, J. Clin. Oncol., 21, 602, 10.1200/JCO.2003.07.071 Lyseng-Williamson, 2009, Ferric carboxymaltose: a review of its use in iron-deficiency anaemia, Drugs, 69, 739, 10.2165/00003495-200969060-00007 Erichsen, 2005, Oral ferrous fumarate or intravenous iron sucrose for patients with inflammatory bowel disease, Scand. J. Gastroenterol., 40, 1058, 10.1080/00365520510023198 Morhaim, 2016, Iron-deficiency anaemia in the Emergency Room: a new opportunity for the use of intravenous iron, Blood Transfus, 14, 91 Quintana-Díaz, 2016, A fast-track anaemia clinic in the Emergency Department: feasibility and efficacy of intravenous iron administration for treating sub-acute iron deficiency anaemia, Blood Transfus, 14, 126 Quintana-Díaz, 2017, A fast-track anaemia clinic in the Emergency Department: cost-analysis of intravenous iron administration for treating iron-deficiency anaemia, Blood Transfus, 15, 438 Bodnar, 2002, Low income postpartum women are at risk of iron deficiency, J. Nutr., 132, 2298, 10.1093/jn/132.8.2298 World Health Organization. Worldwide prevalence of anaemia 1993–2005. Available from: http://www.who.int/nutrition/publications/micronutrients/anaemia_iron_deficiency/9789241596657/en [accessed 20.05.17]. Calvet, 2016, Cost-minimization analysis favours intravenous ferric carboxymaltose over ferric sucrose or oral iron as preoperative treatment in patients with colon cancer and iron deficiency anaemia, Technol. Health Care, 24, 111, 10.3233/THC-151074